Health

Results: 37-48 of 8946

EAACI Calls for a "Vision Zero" Future Free from Allergy and Asthma Burden

Peer-reviewed Publication Shows that Lateral Pharma's SCP Drugs for Neuropathic Pain Act Via the Novel Target LanCL1

Over 55,000 people already on Simple Online Healthcare's waitlist for UK's first, newly approved oral GLP-1

Jette Nygaard-Andersen Joins LivaNova Board as a New Director

First GLP-1 tablet for weight loss approved in the UK

Merrithew® Expands Global Mindful Movement Leadership with Acquisition of the GYROTONIC® Organization

KFSH Advances Practical AI Applications Driving Transformation Across Specialized Healthcare

Onera hPSG® – Bringing PSG Home.

Onera Will Showcase Its Onera hPSG® Solution at the SLEEP 2026 Conference June 14-17, 2026 in Baltimore, MD, USA.

Dr. Tracy Laabs, incoming Director, Wyss Center Geneva

Wyss Geneva Steps Into Its Next Chapter

Silence Therapeutics Highlights Follow-Up Data at EHA 2026 Demonstrating Durable Efficacy and Potential Best-in-Class Profile for Divesiran in Polycythemia Vera

BeOne Showcases Landmark Phase 3 Data in CLL Patients Aged 80+ at EHA 2026, Reinforcing BRUKINSA Benefit

Takeda’s Zasocitinib Significantly Outperforms Deucravacitinib in Head-to-Head Phase 3 Psoriasis Study, Promising to Redefine Oral Treatment Expectations